{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:05:01Z","timestamp":1793160301094,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","aaojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ophtha.2016.07.028","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T03:16:56Z","timestamp":1474514216000},"page":"2300-2308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"title":["Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay"],"prefix":"10.1016","volume":"123","author":[{"given":"Elisabeth M.","family":"Messmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"von Lindenfels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Kampik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ophtha.2016.07.028_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000150445","article-title":"Inflammatory markers in the tears of patients with ocular surface disease","volume":"40","author":"Acera","year":"2008","journal-title":"Ophthalmic Res"},{"issue":"13","key":"10.1016\/j.ophtha.2016.07.028_bib2","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1167\/iovs.13-12235","article-title":"Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis","volume":"54","author":"Acera","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ophtha.2016.07.028_bib3","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1167\/iovs.08-2476","article-title":"Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome","volume":"50","author":"Chotikavanich","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ophtha.2016.07.028_bib4","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1167\/iovs.05-1382","article-title":"Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium","volume":"47","author":"Corrales","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.ophtha.2016.07.028_bib5","first-page":"4142","article-title":"Differential expression of matrix metalloproteinases and their tissue inhibitors at the advancing pterygium head","volume":"41","author":"Di Girolamo","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ophtha.2004.11.050","article-title":"Inflammatory molecules in the tears of patients with keratoconus","volume":"112","author":"Lema","year":"2005","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2016.07.028_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.ico.0000248384.16896.7d","article-title":"Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis","volume":"26","author":"Rohini","year":"2007","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ophtha.2016.07.028_bib8","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<1773::AID-IMMU1773>3.0.CO;2-B","article-title":"Expression of matrix metalloproteinases by human plasma cells and B lymphocytes","volume":"28","author":"Di Girolamo","year":"1998","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.ophtha.2016.07.028_bib9","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1167\/iovs.04-0299","article-title":"Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells","volume":"45","author":"Li","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ophtha.2016.07.028_bib10","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1167\/iovs.03-1145","article-title":"Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface","volume":"45","author":"Luo","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2016.07.028_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1542-0124(12)70148-9","article-title":"Inflammation in dry eye","volume":"2","author":"Stern","year":"2004","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ophtha.2016.07.028_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9440(10)62232-8","article-title":"Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye","volume":"166","author":"Pflugfelder","year":"2005","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.ophtha.2016.07.028_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren\u2019s syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr Eye Res"},{"issue":"10","key":"10.1016\/j.ophtha.2016.07.028_bib14","first-page":"2283","article-title":"Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2016.07.028_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ophtha.2014.07.048","article-title":"Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease","volume":"122","author":"Aragona","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2016.07.028_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.matbio.2015.01.003","article-title":"Proteomic approaches to uncover MMP function","volume":"44\u201346C","author":"Schlage","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.ophtha.2016.07.028_bib17","first-page":"1056","article-title":"A\u00a0method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex","volume":"17","author":"VanDerMeid","year":"2011","journal-title":"Mol Vis"},{"issue":"1","key":"10.1016\/j.ophtha.2016.07.028_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","article-title":"Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye","volume":"131","author":"Sambursky","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2016.07.028_bib19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","article-title":"Diagnosing the severity of dry eye: a clear and practical algorithm","volume":"98","author":"Baudouin","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2016.07.028_bib20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2016.07.028_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1542-0124(12)70083-6","article-title":"Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ophtha.2016.07.028_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/aos.12012","article-title":"Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications","volume":"92","author":"Sullivan","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2016.07.028_bib23","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0b013e318242fd60","article-title":"Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management","volume":"31","author":"Sullivan","year":"2012","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ophtha.2016.07.028_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/ICO.0000000000000175","article-title":"Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease","volume":"33","author":"Sambursky","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ophtha.2016.07.028_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jtos.2015.12.007","article-title":"Dry eye profiles in patients with a positive elevated surface matrix metalloproteinase 9 point-of-care test versus negative patients","volume":"14","author":"Lanza","year":"2016","journal-title":"Ocul Surf"},{"issue":"9","key":"10.1016\/j.ophtha.2016.07.028_bib26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bjophthalmol-2015-307607","article-title":"Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes","volume":"100","author":"Chan","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2016.07.028_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1542-0124(12)70086-1","article-title":"Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.ophtha.2016.07.028_bib28","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1167\/iovs.11-7266","article-title":"Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays","volume":"52","author":"Boehm","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2016.07.028_bib29","first-page":"862","article-title":"Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease","volume":"16","author":"Enriquez-de-Salamanca","year":"2010","journal-title":"Mol Vis"},{"issue":"11","key":"10.1016\/j.ophtha.2016.07.028_bib30","first-page":"2506","article-title":"Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea","volume":"40","author":"Afonso","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2016.07.028_bib31","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1167\/iovs.12-11361","article-title":"Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease","volume":"54","author":"Teson","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib32","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajo.2014.01.001","article-title":"Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions","volume":"157","author":"Lopez-Miguel","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2016.07.028_bib33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/01.ico.0000160973.04072.a5","article-title":"Estrogen stimulation of proinflammatory cytokine and matrix metalloproteinase gene expression in human corneal epithelial cells","volume":"24","author":"Suzuki","year":"2005","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10875-006-9022-6","article-title":"Matrix metalloproteinase-9 and autoimmune diseases","volume":"26","author":"Ram","year":"2006","journal-title":"J\u00a0Clin Immunol"},{"issue":"7","key":"10.1016\/j.ophtha.2016.07.028_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/ICO.0000000000000449","article-title":"Correlation of tear film osmolarity and 2 different MMP-9 tests with common dry eye tests in a cohort of non-dry eye patients","volume":"34","author":"Schargus","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ophtha.2016.07.028_bib36","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1167\/iovs.11-7627","article-title":"Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests","volume":"53","author":"VanDerMeid","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2016.07.028_bib37","doi-asserted-by":"crossref","first-page":"e1726","DOI":"10.1038\/cddis.2015.98","article-title":"Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland","volume":"6","author":"Mauris","year":"2015","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.ophtha.2016.07.028_bib38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.ophtha.2016.07.028_bib39","first-page":"1703","article-title":"Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant","volume":"41","author":"Sobrin","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.exer.2005.08.019","article-title":"JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells","volume":"82","author":"Li","year":"2006","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.ophtha.2016.07.028_bib41","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","article-title":"Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline","volume":"47","author":"De Paiva","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2016.07.028_bib42","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajo.2004.04.052","article-title":"A\u00a0randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance","volume":"138","author":"Pflugfelder","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2016.07.028_bib43","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2016.07.028_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3109\/02713683.2010.490320","article-title":"Topical cyclosporine in thyroid orbitopathy-related dry eye: clinical findings, conjunctival epithelial apoptosis, and MMP-9 expression","volume":"35","author":"Gurdal","year":"2010","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib45","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","article-title":"Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion","volume":"19","author":"Turner","year":"2000","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2016.07.028_bib47","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1111\/j.1755-3768.2011.02196.x","article-title":"A\u00a0multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients","volume":"89","author":"Brignole-Baudouin","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/ICO.0000000000000366","article-title":"Effect of using a combination of lid wipes, eye drops, and omega-3 supplements on meibomian gland functionality in patients with lipid deficient\/evaporative dry eye","volume":"34","author":"Korb","year":"2015","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.ophtha.2016.07.028_bib49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/02713683.2014.884595","article-title":"Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye","volume":"39","author":"Li","year":"2014","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.ophtha.2016.07.028_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archophthalmol.2007.61","article-title":"Topical omega-3 and omega-6 fatty acids for treatment of dry eye","volume":"126","author":"Rashid","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ophtha.2016.07.028_bib51","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1167\/iovs.12-9724","article-title":"Anti-inflammatory effects of alpha linolenic acid on human corneal epithelial cells","volume":"53","author":"Erdinest","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ophtha.2016.07.028_bib52","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2016.07.028_bib53","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study","volume":"252","author":"Celebi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"10.1016\/j.ophtha.2016.07.028_bib54","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ICO.0000000000000271","article-title":"Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease","volume":"33","author":"Hussain","year":"2014","journal-title":"Cornea"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016307345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642016307345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T07:28:51Z","timestamp":1536391731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642016307345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0161642016307345"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.028","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2016.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}